212 POSTER A phase II study of the KIT inhibitor XL820 in patients with advanced gastrointestinal stromal tumors (GIST) resistant to or intolerant of imatinib and/or sunitinib

A.J. Wagner; S. Yazji; J.A. Morgan; E. Choy; S. George; M. Hohos; M. O'Mara; G.D. Demetri

作者A.J. Wagner; S. Yazji; J.A. Morgan; E. Choy; S. George; M. Hohos; M. O'Mara; G.D. Demetri
卷第6卷
期第12期
文件大小58.78KB
发表时间2008
DOI10.1016/s1359-6349(08)72144-x

发现好书期刊，享受阅读乐趣